Drug Type Fusion protein |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization Mannin Research, Inc.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sepsis | Preclinical | US | Mannin Research, Inc.Startup | 22 Sep 2021 |
COVID-19 | Preclinical | CA | - | |
COVID-19 | Preclinical | US | Mannin Research, Inc.Startup | - |
COVID-19 | Preclinical | US | - | |
COVID-19 | Preclinical | CA | Mannin Research, Inc.Startup | - |